Nickel Mines’ run continues: second kiln delivers first pig iron

|

Published 20-MAR-2019 16:40 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Nickel Mines Limited (ASX:NIC) has advised that the second kiln at the company’s 60% owned Hengjaya Nickel Project has been commissioned and has produced its first nickel pig iron (NPI).

Operation of the first kiln is said to be progressing well and is expected to reach at least 80% of nameplate capacity by early April 2019, while the second kiln is anticipated to reach at least 80% of capacity in early May 2019. Ramp-up to full scale production will be achieved shortly thereafter.

In the commissioning period from the first NPI production (31 January 2019 to 10 March 2019) the first kiln produced 3280 tonnes of NPI, at an average grade of 12.65% for a total of 415 tonnes of nickel.

This commissioning process and ramp-up is consistent with that previously implemented across the 20 existing RKEF lines currently in operation within the Indonesia Morowali Industrial Park.

As announced on 1 February 2019, construction of the company’s 17% owned Ranger Nickel Project has been expedited and commissioning of the first kiln is expected near the end of April 2019 with the second kiln to commence about 45 days later — well ahead of previous guidance of the September 2019 quarter.

Commenting on the commissioning of the second Hengjaya Nickel kiln, Managing Director Justin Werner said, “We are extremely pleased to announce production from the second kiln. Commissioning of both kilns will continue over the coming weeks and we look forward to providing further updates as we progress towards full scale production.

“Progress on the Ranger Nickel project also continues well ahead of schedule and brings Nickel Mines closer to its ambition to become a globally significant low cost nickel producer in partnership with our largest shareholder Shanghai Decent.”

The small cap, which is on the cusp of emerging as a significant player in the global nickel space, is having a good run, now up 78% since its January lows to close at $0.40 today.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X